In a strategic move to advance innovation in the Infection Control and Life Science domain, Metall Zug and Miele have inked a transformative agreement. The deal outlines the creation of a new joint venture, where
Search Results for: lenz & staehelin
Lenz & Staehelin: Vencora announces PTO for Crealogix publicly held
Vencora and CREALOGIX, a global player in digital banking technology, jointly announced today that they have entered into a definitive transaction agreement, under which Vencora agreed to submit an all-cash public tender offer to acquire
Basilea Pharmaceutica, a commercial-stage biopharmaceutical company, announced today that it has entered into an asset purchase agreement with Amplyx Pharmaceuticals, an affiliate of Pfizer, to acquire the rights to fosmanogepix, a clinical-stage broad-spectrum antifungal candidate.
Starrag and Tornos, the two traditional Swiss precision machine tool manufacturers, both listed at the SIX Swiss Exchange, announced on October 26, 2023 that they entered into a merger agreement. Under the terms of the merger, Tornos
Mablink Bioscience, a pre-clinical company pioneering the development of next-generation antibody-drug conjugates via its PSARLinkTM proprietary platform, announced an agreement to be acquired by Eli Lilly and Company. The biotechnology company is developing the next
Walder Wyss has incorporated four new counsels to the firm: Stefan Walder, Iliana Djagova, Joy Malka and Téo Genecand (photographed in order of mention). Stefan Walder is counsel in the corporate/M&A
Nadia Ohlhoff-Smahi Vice-President of the International Arbitration Commission AIJA
Nadia Ohlhoff-Smahi has been appointed Vice-President of the AIJA International Arbitration Commission with effect from 25 August 2023. Nadia is a senior associate in the Geneva office of Lenz & Staehelin, where she practices in the areas
On October 4, 2023, Novartis successfully executed the spin-off of Sandoz by distributing Sandoz shares as a dividend-in-kind to Novartis shareholders and American Depositary Receipts (ADRs) holders. Sandoz shares are now listed on the SIX Swiss Exchange.
Nordic BioSite Group, a portfolio company of Adelis Equity Partners, announced that it has acquired LubioScience, the fastest growing life science distributor in Switzerland. This acquisition is an important step towards Nordic BioSite Group’s
Hans-Jakob Diem has joined Walder Wyss as partner as of 4 September 2023. Diem has been until its new incorporation, partner at Lenz & Staehelin at the Corporate and M&A practice group in Zurich, team